 |
Eubacterial Spores, Purified Suspension, Encapsulated |
|---|---|
| Trade Name | |
| Orphan Indication | Ulcerative colitis |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-27 00:00:00 |
| Sponsor | Seres Therapeutics, Inc.;200 Sidney Street;Cambridge, Massachusetts, 02139 |
Related Access Program